U.S. Food and Staples Retail Stock News

NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab (SCHW) Launches Real Time ACH For RIAs As Civic 50 Streak Hits 10

Charles Schwab (NYSE:SCHW) has launched real-time ACH payments for registered investment advisors through its new API framework. Atomic Insights is rolling out ACH payments integration using Schwab's updated APIs to streamline advisor payment workflows. Schwab has been recognized for the 10th consecutive year as a Civic 50 company for its corporate community impact. Charles Schwab sits at the intersection of brokerage, banking, and advice platforms, and these new real-time ACH tools speak...
NYSE:RHI
NYSE:RHIProfessional Services

Robert Half (RHI) Could Be 7% Undervalued On Sector Wide Staffing Selloff

Robert Half (RHI) is back on investors screens after its shares moved in step with a sector wide slide across staffing and employment services companies, driven by fresh concerns about demand and macro conditions. See our latest analysis for Robert Half. At a share price of US$30.09, Robert Half has seen a 30 day share price return of 11.44% and a 90 day share price return of 21.14%, while the 1 year total shareholder return is down 20.91%. This suggests recent momentum has picked up even as...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Enova International (ENVA) Trades At A 7% Premium As Growth Optimism Builds

Recent trading in Enova International (ENVA) has drawn attention after a strong move in the share price over the past month. This has prompted investors to reassess the company’s financial profile and valuation. See our latest analysis for Enova International. At a latest share price of $216.58, Enova International has seen strong short term momentum, with a 37.50% 30 day share price return and a very large 5 year total shareholder return. Together, these may indicate that investors are...
NasdaqGM:GDS
NasdaqGM:GDSIT

Is GDS Holdings (GDS) Undervalued On Its RMB 30b Data Center Expansion Plan?

GDS Holdings (GDS) is back in focus after announcing a planned investment of over RMB 30 billion in new data centers, along with fresh board changes and a large shelf registration for Class A shares. See our latest analysis for GDS Holdings. GDS Holdings has attracted fresh attention as its share price has fallen 8.03% over the past 30 days and 22.62% over 90 days, even though the 1 year total shareholder return is 5.29% and the 3 year total shareholder return is very large. This suggests...
NYSE:SKY
NYSE:SKYConsumer Durables

Champion Homes (SKY) Is Up 9.4% After ROAD to Housing Act Modernizes Manufactured-Housing Rules

Earlier this week, both chambers of the US Congress passed the bipartisan 21st Century ROAD to Housing Act, which cuts red tape, streamlines environmental reviews, modernizes manufactured-housing rules, and restricts large institutional investors from further expanding single-family home portfolios. This legislation directly targets long-standing regulatory and competitive barriers in the housing market, potentially altering the operating backdrop for manufactured-home producers such as...
NYSE:KR
NYSE:KRConsumer Retailing

Does Kroger (KR) Prioritizing Dividends and Rewards Clarify Its Long‑Term Capital Allocation Strategy?

Kroger recently approved its 20th consecutive annual dividend increase, lifting the payout to US$1.56 per year, with the next quarterly dividend of US$0.39 per share scheduled for September 1, 2026, for shareholders of record on August 15, 2026. This higher dividend, alongside refreshed loyalty benefits that let members redeem Points for groceries or fuel, underlines management’s emphasis on both shareholder returns and everyday customer value amid ongoing cost and execution pressures. We’ll...
NYSE:ELV
NYSE:ELVHealthcare

The Bull Case For Elevance Health (ELV) Could Change Following Health OS, CNSide Coverage Expansion - Learn Why

CNSide Diagnostics announced a national agreement with Elevance Health, effective May 1, 2026, extending access to its CNSide cerebrospinal fluid tumor cell enumeration assay to about 45.4 million people and lifting total contracted coverage to 126 million lives across the US. Together with Elevance Health’s Health OS data platform, which has already processed over 250,000 electronic prior authorizations in 2026, these moves highlight the company’s push to tie advanced diagnostics and...
NasdaqGS:RGEN
NasdaqGS:RGENLife Sciences

Moderated 2026 Guidance and Sector Weakness Might Change The Case For Investing In Repligen (RGEN)

In Q1 2026, institutional investors reported that Repligen’s updated 2026 guidance, including moderated revenue and organic growth expectations, weighed on fund performance as market sentiment toward life-sciences tools weakened. An interesting wrinkle is that some investors highlighted Repligen’s lack of exposure to pressured National Institutes of Health funding and management’s earlier bullish tone, underscoring how broader sector mood can influence sentiment even when company-specific...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

How Investors Are Reacting To Construction Partners (ROAD) Refinancing Its Term Loan B And Adding Debt

On June 18, 2026, Construction Partners, Inc. amended its Term Loan B Credit Agreement, refinancing existing term loans, adding US$300.0 million of incremental term loans maturing November 1, 2031, and slightly lowering interest margins subject to leverage conditions. The amendment also introduces modestly more flexible covenants and the ability to exclude certain “Immaterial Subsidiaries” from guarantees, potentially giving the company greater financial and operational flexibility as it...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

GeneDx Holdings (WGS) Names Mark Gardner President, Is It Still Below Fair Value?

Why Mark Gardner’s Appointment Matters For GeneDx Holdings Stock GeneDx Holdings (WGS) has drawn fresh attention after appointing Mark Gardner as President, a leadership change focused on commercial execution and operational scale that could influence how investors view the company’s long-term direction. See our latest analysis for GeneDx Holdings. The appointment of Mark Gardner comes as GeneDx Holdings trades at US$63.54, with a 1 day share price return of 9.4% and a 30 day share price...
NYSE:ORC
NYSE:ORCMortgage REITs

The Bull Case For Orchid Island Capital (ORC) Could Change Following Expanded Buyback And Updated Book Value Estimate

Orchid Island Capital, Inc. recently expanded its stock repurchase authorization to up to 26,612,580 shares, representing about 13.3% of its outstanding common stock, with no set termination date and flexibility across open market and privately negotiated transactions. Alongside the enlarged buyback capacity, the company estimated its book value per share at roughly US$7.24 to US$7.28 as of June 18, 2026, highlighting balance sheet metrics that are central to how investors may assess the...
NYSE:SUI
NYSE:SUIResidential REITs

REIT Stocks In Focus As Fed Pause Puts Rate Sensitive Property Plays Back On Radar

Interest rate sensitive Real Estate Investment Trusts, or REITs, sit right in the crosshairs of the Federal Reserve’s recent signal that it may pause rate hikes, especially as inflation data shows signs of cooling. Stable borrowing costs can affect property values, refinancing decisions, and investor appetite for income focused stocks. This article looks at three REIT stocks from our screener that appear especially exposed to the latest Fed and inflation headlines. It outlines how each stock...
NasdaqGM:BLZE
NasdaqGM:BLZEIT

Backblaze (BLZE) On CoreWeave Deal Has A Pricey AI Growth Narrative

Backblaze (BLZE) is back in focus after signing a multi exabyte cloud storage agreement with AI infrastructure provider CoreWeave, a five year deal valued at about US$335 million. See our latest analysis for Backblaze. The CoreWeave agreement has arrived at a time when momentum in Backblaze has already been strong, with a 30 day share price return of 56.06% and a 90 day share price return of 241.03% feeding into a 1 year total shareholder return of 123.74%. If this AI storage contract has you...
NYSE:CHD
NYSE:CHDHousehold Products

How Slower Organic Growth And Flat Sales Forecasts At Church & Dwight (CHD) Have Changed Its Investment Story

In recent days, coverage of Church & Dwight highlighted that the Arm & Hammer owner has delivered slower organic revenue growth than many consumer staples peers, with analysts now projecting largely flat sales over the coming year. This combination of muted demand expectations and an already optimistic valuation has raised questions about how the company can justify its growth ambitions without clearer drivers. Now, we'll examine how concerns over stagnant near-term revenue expectations...
NYSE:PLD
NYSE:PLDIndustrial REITs

Prologis (PLD) Pushes SEGRO Shareholders After £12.6 Billion Bid Rebuff

Prologis has proposed a £12.6b all stock takeover of UK warehouse group SEGRO. SEGRO's board unanimously rejected the offer, calling it undervalued and opportunistically timed. Prologis is now publicly urging SEGRO shareholders to pressure the board to re engage on the proposal. The situation has drawn attention to potential shifts in the European logistics real estate sector. For investors tracking Prologis (NYSE:PLD), this move comes with the stock around $140.87 and multi year returns...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

CVB Financial (CVBF) Gains Momentum, Is The Stock Already Fully Valued?

Without a specific news headline driving attention, CVB Financial (CVBF) is drawing interest as investors weigh its recent share performance and core banking metrics against the broader regional banking sector. See our latest analysis for CVB Financial. CVB Financial’s recent share price return of 2.32% over 1 day, 7.19% over 7 days and 8.35% over 30 days contributes to an 18.10% year to date share price return and a 19.52% 1 year total shareholder return. This suggests that momentum has been...
NYSE:VLO
NYSE:VLOOil and Gas

Valero Energy (VLO) Stock After 83% Year Gain Is There Still Upside Potential

If you are wondering whether Valero Energy stock still offers value after a strong run, this article walks through what the current price could mean for you. With the share price at US$242.43 and returns of 1.1% over 7 days, a decline of 1.8% over 30 days, 46.7% year to date and 83.2% over 1 year, many investors are asking whether the recent performance already reflects the key positives or changes in risk. Recent headlines around Valero Energy have focused on broader energy sector trends...
NYSE:DMC
NYSE:DMCFood

Del Monte (FDP) Marks Pineapple Day As DMC Ticker Change Nears

Del Monte (NYSE:FDP) is marking International Pineapple Day by spotlighting its pineapple portfolio, including Pinkglow®, Honeyglow®, and Rubyglow® varieties. The company is using the celebration to emphasize its role in making pineapple an everyday staple across global markets. Del Monte plans to change its stock symbol to DMC, signaling an updated approach to global brand stewardship. The ticker change is described as imminent, aligning with the company’s broader push into new markets and...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Stock Faces Margin Stagnation As Earnings Growth Narrative Gets Tested

FedEx (FDX) has wrapped up FY 2026 with fourth quarter revenue of US$25.0 billion, basic EPS of US$6.63 and quarterly net income of US$1,598 million, setting the tone for how investors will read the latest numbers against the broader story. Over the last two reported fourth quarters, revenue has gone from US$22.2 billion to US$25.0 billion, while basic EPS has shifted from US$6.92 to US$6.63, giving you a clear view of how the top and bottom lines are tracking into the current year. With one...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Stock After 410% Five Year Run Is There Still Value?

If you are wondering whether Eli Lilly stock still offers fair value after its strong run, this article walks through what the current price might imply about future expectations. At a last close of US$1,117.26, Eli Lilly has returned 0.5% over the past week, 4.9% over the past month, 3.4% year to date and 42.0% over the past year, with a very large 3 year gain of 148.8% and 5 year gain of 410.3% helping to shape sentiment around the stock. Recent coverage around Eli Lilly has focused on its...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Could Be 40% Below Fair Value On Lawsuit And Trial Risk

Erasca (ERAS) is under pressure after a series of securities class action filings tied to its lead oncology candidate ERAS-0015, patent and trade secret allegations, and preliminary trial data that included a reported patient death. See our latest analysis for Erasca. Erasca’s recent legal headlines came after a period of very strong momentum, with a year to date share price return of 319.22% and a very large 1 year total shareholder return. However, the 90 day share price return of 0.53%...
NYSE:MPLX
NYSE:MPLXOil and Gas

How Investors Are Reacting To MPLX (MPLX) Ahead of Its August Earnings and Value-Focused Valuation

MPLX LP recently outperformed key market indices as investors looked ahead to its August 4, 2026 earnings report, which analysts expected to show modest year-over-year gains in earnings per share and revenue. This growing attention, coupled with MPLX trading at a forward price-to-earnings multiple below the industry average, has drawn interest from investors focused on potential value opportunities in the midstream space. Now we’ll examine how investor anticipation around the August earnings...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Stock After 170% Year Rally Are Valuation Concerns Warranted

If you are wondering whether Modine Manufacturing stock still offers value after its strong run, this article will walk through how the current price stacks up against several valuation checks. The stock last closed at US$276.70, with returns of 6.2% over the past month, 96.5% year to date and 170.4% over the past year. The three and five year returns are very large at roughly 7x and more than 15x respectively. Recent coverage of Modine Manufacturing has focused on how the stock's long term...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

First Solar (FSLR) Could Be 2% Above Fair Value On Tariff And AI Demand Optimism

Recent analyst upgrades have put First Solar (FSLR) in focus after firms highlighted the company’s exposure to U.S. tariffs, strong utility-scale solar demand, solid margins, and an extensive contracted backlog tied to AI data center growth. See our latest analysis for First Solar. First Solar’s share price has cooled in the short term, with a 1-month share price return down 8% and a 7-day return down 3.6%. However, the 90-day share price return of 30.5% and 1-year total shareholder return of...